CD4 and COVID-19: Using megapools of overlapping or prediction-based peptides covering the SARS-CoV-2 proteome, Weiskopf et al. found CD4+ and CD8+ T cells showed activation marker expression in 10 out of 10 and eight out of 10 patients with severe COVID-19 during hospitalization, respectively (9), though their function was not characterized.